These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26060068)

  • 1. Isolation and Validation of Anti-B7-H4 scFvs from an Ovarian Cancer scFv Yeast-Display Library.
    Dangaj D; Scholler N
    Methods Mol Biol; 2015; 1319():37-49. PubMed ID: 26060068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
    Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
    Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
    Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
    Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of anti-B7-H4-scFv library and screening and identification of anti-B7-H4-scFv].
    Shao L; Xu C; Ji H; Mao W; Wang Y; Liu X; Zhu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1260-6. PubMed ID: 27609584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction, expression and functional analysis of anti-B7-H4- scFv-CH3 recombinant antibody.
    Ji H; Guo J; Yang Y; Xu C; Mao W
    J Biosci; 2018 Sep; 43(4):661-671. PubMed ID: 30207312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response.
    Lin TY; Tsai TH; Chen CT; Yang TW; Chang FL; Lo YN; Chung TS; Cheng MH; Chen WC; Tsai KC; Lee YC
    Exp Anim; 2021 Aug; 70(3):333-343. PubMed ID: 33716253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient construct of a large and functional scFv yeast display library derived from the ascites B cells of ovarian cancer patients by three-fragment transformation-associated recombination.
    Yuan X; Chen X; Yang M; Hu J; Yang W; Chen T; Wang Q; Zhang X; Lin R; Zhao A
    Appl Microbiol Biotechnol; 2016 May; 100(9):4051-61. PubMed ID: 26782745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
    Smith JB; Lanitis E; Dangaj D; Buza E; Poussin M; Stashwick C; Scholler N; Powell DJ
    Mol Ther; 2016 Nov; 24(11):1987-1999. PubMed ID: 27439899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
    Leung J; Suh WK
    J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer.
    Fauci JM; Straughn JM; Ferrone S; Buchsbaum DJ
    Gynecol Oncol; 2012 Nov; 127(2):420-5. PubMed ID: 22910694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
    Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
    Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis.
    Chen L; Lu Y; Wang F; Zhou M; Chu Y; Ding W; Liu C; Xie J; Wu C; Jiang J
    Immunol Lett; 2013; 154(1-2):25-30. PubMed ID: 23973734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.
    Zhao A; Nunez-Cruz S; Li C; Coukos G; Siegel DL; Scholler N
    J Immunol Methods; 2011 Jan; 363(2):221-32. PubMed ID: 20837020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.
    Sun SQ; Jiang CG; Lin Y; Jin YL; Huang PL
    J Int Med Res; 2012; 40(2):497-506. PubMed ID: 22613410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could B7-H4 serve as a target to activate anti-cancer immunity?
    Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
    Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
    Hong B; Qian Y; Yao HP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
    Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
    Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
    MacGregor HL; Ohashi PS
    Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.